Facial Plast Surg
DOI: 10.1055/a-2541-2644
Original Research

5-Fluorouracil in Facial Plastic Surgery: Indications, Efficacy, and Safety – A Systematic Review and Narrative Synthesis

1   Department of Otolaryngology, Head and Neck Surgery, Facial Plastic Surgery Unit, King Saud University College of Medicine, Riyadh, Riyadh Province, Saudi Arabia
,
Mohammed Jomah
1   Department of Otolaryngology, Head and Neck Surgery, Facial Plastic Surgery Unit, King Saud University College of Medicine, Riyadh, Riyadh Province, Saudi Arabia
,
Naif Alshehri
2   College of Medicine, King Saud University, Riyadh, Riyadh Province, Saudi Arabia
,
Hamad F. Alrabiah
2   College of Medicine, King Saud University, Riyadh, Riyadh Province, Saudi Arabia
,
Abdullah Binghaith
2   College of Medicine, King Saud University, Riyadh, Riyadh Province, Saudi Arabia
,
Khalid AlOsaimi
2   College of Medicine, King Saud University, Riyadh, Riyadh Province, Saudi Arabia
,
Lulu Aldhwaihy
3   Department of Otolaryngology, Head & Neck Surgery, Security Forces Hospital in Riyadh, Riyadh, Riyadh Province, Saudi Arabia
,
Alaa Baghazal
4   Department of Ophthalmology, AlSalamah Hospital, Jeddah, Makkah Province, Saudi Arabia
,
Hassan Bogari
5   College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah, Makkah Province, Saudi Arabia
› Institutsangaben

Abstract

5-Fluorouracil (5-FU) is an antimetabolite that inhibits fibroblast proliferation and collagen synthesis, making it valuable in facial plastic surgery for scar modulation and other conditions. This systematic review examines the indications, outcomes, and safety of 5-FU in facial plastic surgery. Due to methodological heterogeneity across studies, a narrative synthesis was performed. A comprehensive search of MEDLINE, Cochrane, SCOPUS, EMBASE, PubMed, and Web of Science identified 32 eligible studies (1,456 patients) from 4,772 screened articles. Indications included keloids, hypertrophic scars, contractures, periocular scars, granulomas from filler complications, nasal skin thickening, infections following thread lifts, resistant facial warts, and hypochromic lesions. Most studies reported reductions in scar size, erythema, and recurrence rates, with combination therapies enhancing outcomes. Adverse effects were mild and transient. However, variability in dosing, administration frequency, and follow-up underscores the need for standardized treatment guidelines and long-term studies.



Publikationsverlauf

Accepted Manuscript online:
18. Februar 2025

Artikel online veröffentlicht:
05. März 2025

© 2025. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Conejo-Mir JS, Sanz Guirado S, Angel Muñoz M. Adverse granulomatous reaction to Artecoll treated by intralesional 5-fluorouracil and triamcinolone injections. Dermatol Surg 2006; 32 (08) 1079-1081 , discussion 1082
  • 2 Khalid FA, Farooq UK, Saleem M. et al. The efficacy of excision followed by intralesional 5-fluorouracil and triamcinolone acetonide versus excision followed by radiotherapy in the treatment of ear keloids: a randomized control trial. Burns 2018; 44 (06) 1489-1495
  • 3 Irvine LE, Nassif PS. Use of 5-fluorouracil for management of the thick-skinned nose. Facial Plast Surg 2018; 34 (01) 9-13
  • 4 Trace AP, Enos CW, Mantel A, Harvey VM. Keloids and hypertrophic scars: a spectrum of clinical challenges. Am J Clin Dermatol 2016; 17 (03) 201-223
  • 5 Katz TM, Glaich AS, Goldberg LH, Friedman PM. 595-nm long pulsed dye laser and 1450-nm diode laser in combination with intralesional triamcinolone/5-fluorouracil for hypertrophic scarring following a phenol peel. J Am Acad Dermatol 2010; 62 (06) 1045-1049
  • 6 Wiest LG, Stolz W, Schroeder JA. Electron microscopic documentation of late changes in permanent fillers and clinical management of granulomas in affected patients. Dermatol Surg 2009; 35 (Suppl. 02) 1681-1688
  • 7 Cartron AM, Blaszczak A, Trinidad JC. Combination therapy with 5-fluorouracil and salicylic acid in a treatment-resistant case of filiform facial warts. Dermatol Ther 2020; 33 (02) e13235
  • 8 Arbache S, Arbache ST, Hirata SH. Is it possible to repigment iatrogenic and traumatic hypochromic lesions? A case series using the MMP drug delivery technique with 5-fluorouracil and bleomycin. Int J Dermatol 2022; 61 (01) 71-83
  • 9 Lee BW, Levitt AE, Erickson BP. et al. Ablative fractional laser resurfacing with laser-assisted delivery of 5-fluorouracil for the treatment of cicatricial ectropion and periocular scarring. Ophthalmic Plast Reconstr Surg 2018; 34 (03) 274-279
  • 10 Marquez JL, Sudduth JD, Ormiston L, Patel BC, Gociman B. Multimodal management of facial keloid with tissue expansion, excision, and injection of 5-FU and triamcinolone. Plast Reconstr Surg Glob Open 2023; 11 (01) e4796
  • 11 Anggawirya BY, Wardhani PH, Indramaya DM, Listiawan MY. Combination of fractional Er:YAG laser, pulsed dye laser, and intralesional triamcinolone with 5-fluorouracil for keloid treatment. J Lasers Med Sci 2023; 14: e30
  • 12 Or L, Eviatar JA, Massry GG, Bernardini FP, Hartstein ME. Xanthelasma-like reaction to filler injection. Ophthalmic Plast Reconstr Surg 2017; 33 (04) 244-247
  • 13 Page MJ, McKenzie JE, Bossuyt PM. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372: n71
  • 14 Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev 2016; 5 (01) 210
  • 15 Sterne JAC, Savović J, Page MJ. et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019; 366: l4898
  • 16 Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg 2003; 73 (09) 712-716
  • 17 Murad MH, Sultan S, Haffar S, Bazerbachi F. Methodological quality and synthesis of case series and case reports. BMJ Evid Based Med 2018; 23 (02) 60-63
  • 18 Ismail SA, Mohammed NHK, Sotohy M, Abou-Taleb DAE. Botulinum toxin type A versus 5-Fluorouracil in treatment of keloid. Arch Dermatol Res 2021; 313 (07) 549-556
  • 19 Levenberg A, Vinshtok Y, Artzi O. Potentials for implementing pressure-controlled jet injection in management of keloids with intralesional 5FU and corticosteroids. J Cosmet Dermatol 2020; 19 (08) 1966-1972
  • 20 Madura C, Nayak PB, Raj PR, Chandrashekar BS. Surgical approach in the management of ear keloids: our experience with 30 patients. Int J Dermatol 2021; 60 (12) 1553-1560
  • 21 Goel R, Khanam S, Shah S, Saran RK. Challenges in the management of upper lid keloid. Case Rep Ophthalmol Med 2022; 2022: 3032246
  • 22 Wu H, Dong G, Hu J. et al. Contour first-retrospective study of an algorithmic approach of auricular keloids. J Cosmet Dermatol 2023; 22 (04) 1304-1311
  • 23 Sivakumar S, Thenmozhi MD, Sethuraja K, Ashwin Raja A. A novel approach of neoadjuvant and adjuvant therapy with surgery for large keloids of the ear. Asian J Med Sci 2023; 14: 209-218
  • 24 Talei B, Raskin J, Borrelli M, Desales A. Contracture treatment with 5-FU. Ear Nose Throat J 2021; 100 (Suppl. 06) 876S-878S
  • 25 Fitzpatrick RE. Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol Surg 1999; 25 (03) 224-232
  • 26 Erickson T, Gray J, Tayebi B, Tung R. A multimodal approach to the treatment of extensive burn scars: a modified subcision technique for intralesional delivery of corticosteroid and 5-fluorouracil in combination with several procedural laser therapies; a case report. Scars Burn Heal 2018; 4: 2059513118818997
  • 27 Wei J, Du L, Cao Z. et al. 5-aminolevulinic acid photodynamic therapy combined with intralesional triamcinolone and 5-fluorouracil to treat acne hypertrophic scar. Clin Cosmet Investig Dermatol 2023; 16: 3057-3064
  • 28 Rosa-Nieves PM, Plampton K, Evans T, Whitley MJ. Successful treatment of a keloid with surgical excision followed by pentoxifylline, intralesional corticosteroid, and intralesional 5-fluorouracil. Dermatol Surg 2023; 49 (10) 972-974
  • 29 Apikian M, Goodman G. Intralesional 5-fluorouracil in the treatment of keloid scars. Australas J Dermatol 2004; 45 (02) 140-143
  • 30 Khare N, Patil SB. A novel approach for management of ear keloids: results of excision combined with 5-fluorouracil injection. J Plast Reconstr Aesthet Surg 2012; 65 (11) e315-e317
  • 31 Goldan O, Weissman O, Regev E, Haik J, Winkler E. Treatment of postdermabrasion facial hypertrophic and keloid scars with intralesional 5-fluorouracil injections. Aesthetic Plast Surg 2008; 32 (02) 389-392
  • 32 Massry GG. Cicatricial canthal webs. Ophthalmic Plast Reconstr Surg 2011; 27 (06) 426-430
  • 33 Kalasho BD, Kikuchi R, Zoumalan CI. Silicone-based scar cream for post-upper eyelid blepharoplasty-associated cicatricial and hypertrophic scarring. J Drugs Dermatol 2019; 18 (05) 440-446
  • 34 Gupta R, Thomas R, Almukhtar F, Kiran A. Use of 5-fluorouracil injections in traumatic cicatricial malposition of eyelids. Plast Reconstr Surg 2022; 150 (03) 713e-714e
  • 35 Stewart KJ, Joseph SS, Douglas RS. An aesthetic orbicularis oculi myectomy technique for blepharospasm: Use of topical 5-fluorouracil and fibrin sealant. Ophthalmic Plast Reconstr Surg 2018; 34 (04) 342-345
  • 36 Yoo DB, Peng GL, Massry GG. Effacing the orbitoglabellar groove with transposed upper eyelid fat. Ophthalmic Plast Reconstr Surg 2013; 29 (03) 220-224
  • 37 Sivam S, Mackay C, Humphrey C, Kriet JD. Giant PMMA foreign body granulomas with imaging. J Cutan Aesthet Surg 2023; 16 (03) 256-258
  • 38 Jia X, Huang L, Hu J. A rare symptom of secondary infection after facial thread lift and its treatment. J Craniofac Surg 2023; 34 (02) e204-e205